Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
DSM-Firmenich AGDSMFF 57 EV-to-EBITDA is 6.00 as of Jul. 28, 2026, which is 62% below its 10-year median of 15.78. GuruFocus rates DSMFF with a GF Score™ of 57/100 and a GF Value™ of $89.10 (Fairly Valued). The stock has 8 warning signs investors should review. Among 1,319 Chemicals companies, DSM-Firmenich AG ranks better than 80.52% on this metric.
EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, DSM-Firmenich AG's enterprise value is $26,903 Mil.
DSM-Firmenich AG's EBITDA for the trailing twelve months (TTM) ended in Dec. 2025 was $4,483 Mil. Therefore, DSM-Firmenich AG's EV-to-EBITDA for today is 6.00.
The historical rank and industry rank for DSM-Firmenich AG's EV-to-EBITDA or its related term are showing as below:
DSMFF'
s EV-to-EBITDA Range Over the Past 10 Years
Min: 4.79 Med: 15.78 Max: 62.15
Current: 6.14
During the past 4 years, the highest EV-to-EBITDA of DSM-Firmenich AG was 62.15. The lowest was 4.79. And the median was 15.78.
DSMFF's EV-to-EBITDA is ranked better than 80.52% of 1319
companies
in the Chemicals industry
Industry Median: 13.39
vs DSMFF: 6.14
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.
The "classic" EV-to-EBITDA is much better in capturing debt and net cash than the PE Ratio (TTM).
DSM-Firmenich AG (OTCPK:DSMFF) EV-to-EBITDA Explanation
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
DSM-Firmenich AG's PE Ratio (TTM) for today is calculated as:
DSM-Firmenich AG's share price for today is $91.31.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. DSM-Firmenich AG's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2025 was $-5.034.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio (TTM).
The historical data trend for DSM-Firmenich AG's EV-to-EBITDA can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Specialty Chemicals subindustry, DSM-Firmenich AG's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
DSM-Firmenich AG EV-to-EBITDA vs Chemicals Industry
For the Chemicals industry and Basic Materials sector, DSM-Firmenich AG's EV-to-EBITDA distribution charts can be found below:
* The bar in red indicates where DSM-Firmenich AG's EV-to-EBITDA falls into.
DSM-Firmenich AG's current Enterprise Value is $26,903 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. DSM-Firmenich AG's EBITDA for the trailing twelve months (TTM) ended in Dec. 2025 was $4,483 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
DSM-Firmenich AG (DSMFF) has a EV-to-EBITDA of 6.00 as of Jul. 28, 2026. EV to EBITDA ratio is the company's enterprise value divided by earnings before interest, taxes, depreciation and amortization. View historical data on DSM-Firmenich AG. This is 62% below median its historical median of 15.78. Over the past decade, DSM-Firmenich AG's EV-to-EBITDA has ranged from 4.79 to 62.15. According to the industry distribution chart, DSM-Firmenich AG ranks #257 out of 1319 companies in the Chemicals industry, placing it in the top 19.5%.
Is DSM-Firmenich AG's EV-to-EBITDA too high?
DSM-Firmenich AG's current EV-to-EBITDA of 6.00 is 62% below median its 10-year median of 15.78. Over the past 10 years, this metric has ranged from a low of 4.79 to a high of 62.15. The Chemicals industry median EV-to-EBITDA is 13.39. DSM-Firmenich AG's value of 6.00 is 55.2% below this industry median. Based on the distribution chart, DSM-Firmenich AG ranks #257 out of 1319 companies in the Chemicals industry, which is in the top quartile — a strong position relative to peers. Overall, DSM-Firmenich AG has a GF Score™ of 57/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does DSM-Firmenich AG's EV-to-EBITDA compare to LIN and SHW?
According to the Chemicals industry distribution chart, DSM-Firmenich AG ranks #257 out of 1319 companies for EV-to-EBITDA. This places DSM-Firmenich AG in the top 20% of its industry — outperforming the majority of peers. The industry median EV-to-EBITDA is 13.39. DSM-Firmenich AG's value of 6.00 is 55.2% below this benchmark. Historically, DSM-Firmenich AG's own EV-to-EBITDA has ranged from 4.79 to 62.15 over the past decade. While the company's 10-year median is 15.78 vs. the industry median of 13.39, DSM-Firmenich AG has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-EBITDA for a Chemicals company?
The median EV-to-EBITDA among Chemicals companies is 13.39, based on 1,319 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-EBITDA significantly above this median, while those in the bottom quartile fall well below. However, EV-to-EBITDA should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. DSM-Firmenich AG's current EV-to-EBITDA of 6.00 is 55.2% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-EBITDA mean?
A high EV-to-EBITDA can signal that a stock is expensive relative to its fundamentals. EV to EBITDA ratio is the company's enterprise value divided by earnings before interest, taxes, depreciation and amortization. View historical data on DSM-Firmenich AG. For the Chemicals industry, the median EV-to-EBITDA is 13.39 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. DSM-Firmenich AG's current EV-to-EBITDA is 6.00, which is 62% below median its own 10-year median of 15.78. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is DSM-Firmenich AG stock overvalued right now?
Based on GuruFocus' analysis, DSM-Firmenich AG (DSMFF) is currently considered Fairly Valued. The stock's GF Value™ is $89.10, compared to a current price of $91.31 — trading 2.5% above its estimated fair value. The current EV-to-EBITDA is 6.00, which is 62% below median its 10-year median of 15.78 and 55.2% below the Chemicals industry median of 13.39. DSM-Firmenich AG's overall GF Score™ is 57/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-EBITDA calculated?
EV-to-EBITDA is calculated from a company's financial statements. For DSM-Firmenich AG (DSMFF), the current EV-to-EBITDA is 6.00 as of Jul. 28, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is DSM-Firmenich AG (DSMFF) Overvalued in 2026?
Based on GuruFocus' analysis, DSM-Firmenich AG stock appears to be overvalued.
The current stock price of $91.31 is trading 2.5% above its estimated GF Value™ of $89.10.
GuruFocus considers DSM-Firmenich AG to be Fairly Valued.
Key valuation signals for DSMFF:
EV-to-EBITDA: 6.00 (62% below median its 10-year median of 15.78)
GF Value™: $89.10 vs. price of $91.31 (2.5% above fair value)
Industry Position: 55.2% below the Chemicals median (#257 of 1319)
No single metric tells the full story. See the DSMFF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
DSM-Firmenich is a global science-based company formed in 2023 through the merger of DSM, a Dutch nutrition, health, and sustainable living player, and Switzerland-based Firmenich, the third-largest player in the flavor and fragrance market. The company serves a wide range of end-consumer markets providing nutrition solutions ranging from medical and early-life nutrition, fragrances for personal-, home-, and laundry-care brands, prestige perfumes, and other ingredients for food and beverage, home, and personal care. DSM-Firmenich has nearly 30,000 employees, with more than 2,000 scientists and engineers spread across 15 research and development facilities.
57GF Score
Get the complete analysis for DSMFF
EV-to-EBITDA is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
DSMFF has been successfully added to your 
